Understanding how a protein involved in cilia function affects certain genetic disorders.
Signaling Mechanisms and Cellular Functions of a Ciliopathy-Associated Protein Kinase
This study is looking at a protein called CILK1 to understand how it affects the length and formation of tiny hair-like structures in our cells, which can cause problems in certain genetic disorders known as ciliopathies, and the findings could help develop new treatments for people with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10775815 on NIH RePORTER |
What this research studies
This research investigates the role of the CILK1 protein kinase in ciliopathies, which are disorders caused by dysfunctional cilia due to genetic mutations. The study aims to uncover how CILK1 regulates cilia length and formation, and to identify its substrates that contribute to the ciliopathy phenotype. By exploring the molecular mechanisms behind these processes, the research seeks to fill existing knowledge gaps about cilia's structure and function. Patients may benefit from insights that could lead to new therapeutic strategies for ciliopathies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with ciliopathies or related genetic disorders.
Not a fit: Patients without genetic mutations affecting cilia function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with ciliopathies.
How similar studies have performed: While the specific focus on CILK1 is novel, similar research on cilia dysfunction has shown promising results in understanding related disorders.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Fu, Zheng — University of Virginia
- Study coordinator: Fu, Zheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.